Wouldn’t it be cool to breathe into a cellphone and have it screen for diseases or health issues before you see a doctor? Studies have shown that this might be feasible.
This project originated as a venture-funded low-cost Covid-19 tester in the 2020-2021 academic year. That year the BME team chose to investigate an electronic nose (e-nose) to smell breath biomarkers, such as volatile organic compounds (VOCs). Research papers showed that e-nose technology could detect many human health conditions including Covid-19, asthma, COPD, liver disease, and lung cancer. By May 2021, the team had designed a first prototype, the Sniftek 5, which used five metal oxide semiconductor (MOS) sensors. In the 2021-2022 academic year, a new team used the Sniftek 5 device to do extensive testing of VOCs. They also designed an improved device, the Sniftek 36, and filed two provisional patents.
2022-2023 was the last year for venture funding, so the team focused on designing, prototyping, validating, and manufacturing a breath analysis device for a customer that would purchase them. The result was the BreathConnect, which is an internet-connected alcohol breathalyzer. The 2022-2023 team also developed a proof-of-concept model of a better and more accurate test device, called the breath machine. The BreathConnect breathalyzer uses an electrochemical sensor. This product was created to help start Sniftek, Inc, a commercial company, which is paying for the 2023-2024 project.
Department:
School of Biomedical Engineering
Advisors:
Bert Vermeulen, Kevin Lear, and Nick Grant